Concepedia

Mei-Chu Lo

ML

Statistics

Publications

27

Citations

2.3K

H-Index

21

Active since

1997

Affiliations

Amgen (United States)(Current)

Princeton University

Pearl River Community College

Université Bourgogne Franche-Comté

Women's Health Research Institute

Mei-Chu Lo is an author at Amgen (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1997–2025

27

Publications

27

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery

Mei-Chu Lo, Ann Aulabaugh, Guixian Jin et al. · Analytical Biochemistry · 2004 · 685 citations

, , +14

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

, , +7

A “Click Chemistry Platform” for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation

Ryan P. Wurz, Ken Dellamaggiore, Hannah Dou et al. · Journal of Medicinal Chemistry · 2017 · 204 citations

, , +17

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

, , +14

A New Mechanism of Action Proposed for Ramoplanin

Mei-Chu Lo, Hongbin Men, Arthur Branstrom et al. · Journal of the American Chemical Society · 2000 · 87 citations

, , +5

1–5 of 27